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مقارنة بني درجة احلموضة اللعابية وكفاءة معادلة احلموضة والفوسفاتاز القلوية يف 
املدخنني وغري املدخنني األصحاء
دراسة جمموعة استعادية
فاطمة اأحمدي-متمايل، باري�صا فل�صفي، حممد تقي جودارزي، جالل پورالعجل
abstract: Objectives: Saliva contains alkaline phosphatase (ALP)—a key intracellular enzyme related to 
destructive processes and cellular damage—and has buffering capacity (BC) against acids due to the presence 
of bicarbonate and phosphate ions. Smoking may have deleterious effects on the oral environment due to pH 
changes which can affect ALP activity. This study aimed to evaluate the salivary pH, BC and ALP activity of male 
smokers and healthy non-smokers. Methods: This retrospective cohort study took place between August 2012 
and December 2013. A total of 251 healthy male non-smokers and 259 male smokers from Hamadan, Iran, were 
selected. Unstimulated whole saliva was collected from each participant and pH and BC were determined using a 
pH meter. Salivary enzymes were measured by spectrophotometric assay. Results: Mean salivary pH (7.42 ± 0.48 
and 7.52 ± 0.43, respectively; P = 0.018) and BC (3.41 ± 0.54 and 4.17 ± 0.71; P = 0.001) was significantly lower 
in smokers compared to non-smokers. Mean ALP levels were 49.58 ± 23.33 IU/L among smokers and 55.11 ± 
27.85 IU/L among non-smokers (P = 0.015). Conclusion: Significantly lower pH, BC and ALP levels were observed 
among smokers in comparison to a healthy control group. These salivary alterations could potentially be utilised as 
biochemical markers for the evaluation of oral tissue function and side-effects among smokers. Further longitudinal 
studies are recommended to evaluate the effects of smoking on salivary components.
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امللخ�ص: اأهداف: يحتوي اللعاب على الفو�صفاتيز القلوي)ALP(، وهو اإنزمي اأ�صا�صي خلوي مرتبط بتلف اخلاليا والعمليات احليوية ال�صارة. 
يعادل ALP االأحما�ض ب�صبب وجود اأيونات البيكربونات والفو�صفات. قد يكون للتدخني اآثار �صارة على بيئة الفم نتيجة لتغريات درجة 
احلمو�صة التي ميكن اأن توؤثر على ن�صاط ALP. هدفت هذه الدرا�صة اإىل تقييم درجة احلمو�صة اللعابية، وكفاءة معادلة االأحما�ض، ون�صاط 
ALP يف املدخنني وغري املدخنني من الذكور االأ�صحاء. منهجية: هذه درا�صة ا�صتعادية اأجريت يف الفرتة ما بني اأغ�صط�ض 2012 ودي�صمرب 
2013. مت اإختيار 251 من غري املدخنني و 259 من املدخنني الذكور من همدان، اإيران. مت جمع اللعاب الكامل الغري حمفز من كل م�صارك ومت 
حتديد درجة احلمو�صة و وكفاءة معادلة االأحما�ض با�صتخدام جهاز مقيا�ض درجة احلمو�صة. مت قيا�ض االإنزميات اللعابية بوا�صطة الفح�ض 
و 0.48 ± 7.42( وكفاءة معادلة االأحما�ض   7.52 ± 0.43, ;على التوايل   P = 0.018( نتائج: معدل الرقم الهيدروجيني اللعابي  الطيفي. 
)P = 0.001 ;0.71 ± 4.17 و 0.54 ± 3.41( كانتا اأقل ذات بداللة اإح�صائية لدى املدخنني مقارنة بغري املدخنني. كان معدل م�صتويات 
ALP: 23.33 ± 49.58 وحدة دولية/لرت للمدخنني و 27.85 ± 55.11 وحدة دولية/لرت لغري املدخنني )P = 0.015(. خامتة: وجد انخفا�ض 
الغري مدخنة. من  ALP بني املدخنني باملقارنة مع جمموعة املراقبة  ملحوظ لدرجة احلمو�صة، وكفاءة معادلة االأحما�ض وم�صتويات 
املحتمل اأن ت�صتخدم هذه التغريات اللعابية كعالمات كيميائية حيوية لتقييم وظيفة االأن�صجة الفموية واالآثار اجلانبية للتدخني. ين�صح 
م�صتقبال باإجراء درا�صات طولية لتقييم اآثار التدخني على املكونات اللعابية.
كلمات مفتاحية: اللعاب؛ الفو�صفاتيز القلوي؛ االأحما�ض؛ معادل احلمو�صة؛ التدخني.
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Advances in Knowledge 
- Smoking was found to significantly alter salivary pH and buffering capacity (BC), which can have many dangerous and deleterious 
effects on the oral mucosa. 
Application to Patient Care
- This study found significantly lower pH, BC and alkaline phosphatase levels among smokers. These changes could potentially be used as 
biochemical markers to evaluate oral tissue function among smokers.
- Dental and medical practitioners should make patients aware of the effect of smoking on salivary components. The findings of this study 
could be used by healthcare workers to encourage patients to take part in smoking cessation programmes.
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Saliva is an oral fluid secreted from major and minor salivary glands for the primary purposes of digestion, lubrication 
and the protection of tooth integrity.1,2 Overall, 
saliva is composed of 99% water and 1% organic and 
inorganic molecules.1 Important components of saliva 
include electrolytes such as bicarbonate, calcium, 
fluoride and phosphate; enzymes such as α-amylase, 
invertase and mucins; immunoglobulins (Igs) includ-
ing IgA, IgG and IgM; lipids including neutral lipids, 
glycolipids and phospholipids; non-Igs such as 
histidine-rich proteins, lactoferrin and lysozyme; and 
proteins such as peroxidase, proline-rich proteins, 
agglutinins and statherin.1 Alkaline phosphatase (ALP) 
is an intracellular enzyme present in the saliva 
and most tissues, organs and bones, including the 
epithelial, inflammatory cells, bacterial organisms and 
mineralising tissue cells.3–5 The enzyme is related to 
cell injury and death. ALP most commonly correlates 
with bone metabolism and is present in the osteoblast 
cell membrane and polymorphonuclear leukocyte 
granules.3 Destructive processes in the alveolar bone 
can lead to increased ALP activity.4,5
A key factor in enzyme functionality is pH, 
with the optimum pH for ALP activity being ≈ 7.4.6 
Therefore, the maximum enzyme activity of ALP 
is related to the pH and concentration of phosphate 
esters existing in cells.6 Normal salivary pH values 
range from 7.4–7.6, depending on salivary calcium 
and phosphate concentrations.1,7,8 Due to the presence 
of bicarbonate/carbonate ions and, to a lesser extent, 
phosphate ions and proteins, saliva has a buffering 
capacity (BC) and can neutralise acids produced in 
the oral cavity or ingested.9,10 Oral health and integrity, 
demineralisation-remineralisation balance and dilu-
tion and antimicrobial activity are important to 
maintain good salivary BC.11 High salivary pH and BC 
have been found to lead to better oral health outcomes 
and a lower incidence of dental caries.12 Bagherian 
et al. reported lower pH and BC values among children 
without caries.13 In contrast, another study indicated 
lower resting salivary pH values among individuals 
with dental caries.14 However, changes in pH can 
also result in pathological changes to the teeth and 
oral cavity.10 
Cigarette smoke contains harmful components 
such as pyridine alkaloids, aromatic hydrocarbons and 
combustion gases; these can lead to the development 
of various life-threatening diseases.15,16 Moreover, 
smoking has many side-effects which manifest in 
the oral mucosa, including delays in wound healing, 
periodontitis and premalignant and malignant oral 
lesions.16 Due to the deleterious effects of smoking on 
the oral mucosa, associated salivary changes and the 
limited number of studies in this field, the aim of this 
study was to evaluate the salivary pH, BC and ALP 
activity of male smokers and healthy non-smokers in 
Hamadan, Iran. 
Methods
This retrospective cohort study took place between 
August 2012 and December 2013 and included 251 
male non-smokers and 259 male smokers. Participants 
in the smoking group were selected from smokers 
patients attending routine dental examinations at the 
Oral Medicine Department of the Hamadan Dental 
School who had been smoking at minimum of five 
cigarettes a day for at least five years. The control group 
included healthy non-smokers who attended routine 
dental examinations at the Oral Medicine Department 
of the Hamadan Dental School during the study period. 
New smokers and individuals with systemic diseases, 
a history of alcohol and tobacco consumption and/or 
drug treatment were excluded from the study. On the 
basis of a previous study assessing salivary enzymes 
and total antioxidant capacity among smokers and 
non-smokers, the ideal sample size was determined 
to be 258 for each group with a total sample size 
of 516 at a 95% significance level and with 90% 
statistical power.17 
Prior to saliva collection, all participants were 
requested to avoid any oral stimuli for at least 90 
minutes beforehand and smokers were asked to refrain 
from smoking for one hour. Unstimulated whole saliva 
was then collected according to a previously described 
method.18 A total of 5 mL of spat unstimulated saliva 
was collected from each participant in a sterile falcon 
tube. The specimens were immediately centrifuged 
(1,000 g for 10 minutes) at 4 °C. Squamous cells and cell 
debris were removed and the supernatant was isolated. 
Saliva samples were immediately frozen at -80 °C until 
the sample collection period was complete. After this, 
the pH of each saliva sample was determined using 
a pH meter (Hanna Instruments Inc., Ann Arbor, 
Michigan, USA).13 The salivary BC was then evaluated 
by the addition of 1 mL of 0.1 N of hydrochloric acid 
to 1 mL of saliva. The BC was calculated according to 
changes in pH and ranked via the Ericsson method 
as high (pH >5.5), moderate (pH 4.5–5.5) or low (pH 
<4.5).19 Salivary ALP levels were determined using 
a spectrophotometric assay kit (Pars Azmoon Inc., 
Tehran, Iran) by the addition of a P-Nitrophenyl 
phosphate solution. The production of P-Nitrophenol 
in the saliva was evaluated by measuring absorbance at 
450 nm on a spectrophotometer.
Data were analysed using an independent t-test and 
Mann-Whitney U test at the 0.050 significance level by 
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Stata® data analysis and statistical software, Version 12 
(StataCorp LP, College Station, Texas, USA). All values 
were reported as means ± standard deviation.
This study protocol was approved by the Ethics 
Committee of the Hamadan University of Medical 
Sciences & Health (#16/35/4749). Written informed 
consent was obtained from all participants after the 
aims of the study had been explained. 
Results
Overall, participants in both groups ranged in age 
from 20–50 years old. The mean age was 27.76 ± 
6.54 years and 30.98 ± 7.80 years for the smoker and 
control groups, respectively [Table 1]. Smokers had 
significantly lower salivary pH in comparison to non-
smokers (7.42 ± 0.48 versus 7.52 ± 0.43, respectively; 
P = 0.018). Mean levels of salivary BC were also 
significantly lower among smokers compared to non-
smokers (3.41 ± 0.54 versus 4.17 ± 0.71, respectively; 
P = 0.001). Additionally, mean ALP levels were 
significantly lower among smokers in comparison to 
non-smokers (49.58 ± 23.33 IU/L versus 55.11 ± 27.85 
IU/L, respectively; P = 0.015). However, the latter 
difference was not significant according to the Mann-
Whitney U analysis (P = 0.064) [Table 2]. 
Discussion
The composition of saliva can act as a biomarker 
for the diagnosis of certain systemic diseases, 
determination of exposure to harmful substances 
and general assessment of health and disease status.2 
Since the second half of the twentieth century, saliva 
has been used diagnostically; in terms of biological 
testing, saliva has many advantages over serum, 
including easily accessible non-invasive sample 
collection. As such, saliva can play an important role 
in the early detection and monitoring of drug use.20 
Furthermore, various studies have shown that altered 
salivary pH, BC and ALP levels are associated with the 
formation or development of dental caries, gingivitis, 
periodontitis, human immunodeficiency virus (HIV) 
infection, diabetes, orthodontic tooth movements, 
cancer, abdominal inflammatory diseases and the early 
onset of menopause.3,4,12,13,21–29
In the current study, salivary pH was lower among 
smokers in comparison to non-smokers; although 
the mean values found seem to reflect a minimal 
difference between the two groups (7.42 versus 7.52, 
respectively), even very small alterations in pH can 
influence salivary enzyme activity.6 Additionally, BC 
was significant lower among smokers in the current 
study. In previous research, salivary pH and BC values 
were reportedly lower among HIV-positive patients; 
this reduction correlated with an increase in the 
degree of immunosupression.24 Salivary pH has also 
been reported to be lower and BC higher in post-
menopausal women.21 Age may also have an effect on 
BC; in one study, BC was found to be higher among 
the elderly.22 However, no significant differences in pH 
and BC were noted among individuals with different 
stages of periodontal disease.22 
In the current study, ALP activity levels were 
significantly lower in the smoker group than the control 
group, which may indicate the effect of smoking on 
salivary enzymes. The lower ALP levels observed among 
Table 1: Age profile of male smokers and healthy non-
smokers in Hamadan, Iran (N = 510)






20–30 188 (72.6) 128 (51)  
 
0.00131–40 53 (20.5) 83 (33.1)
41–50 18 (6.9) 40 (15.9)
Mean ± SD 27.76 ± 6.54 30.98 ± 7.80
SD = standard deviation.
Table 2: Salivary pH, buffering capacity and alkaline phosphatase levels among male smokers and healthy non-
smokers in Hamadan, Iran (N = 510)
Variable Mean ± SD
(95% CI)











pH 7.42 ± 0.48 
(0.48–7.37)
7.52 ± 0.43 
(0.43–7.47)
0.10 ± 0.04 
(0.02–0.17)
0.018 -
BC 3.41 ± 0.54 
(3.34–3.47)
4.17 ± 0.71 
(4.08–4.26)
0.77 ± 0.06 
(0.65–0.87)
0.001 -
ALP in IU/L 49.58 ± 23.33 
(46.72–52.43)
55.11 ± 27.85 
(51.65–58.57)
5.54 ± 2.27 
(1.07–10.00)
0.015 0.064
SD = standard deviation; CI = confidence interval; SE = standard error; BC = buffering capacity; ALP = alkaline phosphatase.
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smokers may be explained by hyperkeratinisation of 
the oral and gingival mucosa, which could prevent the 
release of ALP in the saliva. In addition, these changes 
could also be due to the wide age range of participants 
in the current study. In contrast to the findings of the 
current study, some researchers have shown higher 
ALP levels in smokers.30,31 Another study found that 
smoking had no effect on ALP activity.28 Kibayashi 
et al. noted significantly lower levels of salivary ALP 
and albumin in current smokers compared to non-
current smokers; smoking was therefore considered a 
risk factor for periodontitis and a potential biomarker 
for the disease.23 Higher salivary ALP levels have 
also been found among individuals with periodontal 
disease, pancreatitis and appendicitis, with treatment 
of the disease resulting in lowered enzyme levels.3,4,29 
Therefore, non-invasive assessment of ALP levels 
may be useful in the diagnosis and prognosis of 
periodontal tissue function and treatment monitoring 
of abdominal inflammatory diseases.3,29 
Smoking has been found to cause periodontal 
disease and bone destruction.32 However, in the 
current study, smokers with periodontal disease were 
not included and specific side-effects of smoking 
on the oral mucosa were not evaluated. Further 
longitudinal studies among smokers with and without 
oral manifestations in comparison with a healthy 
control group in different age- and gender-matched 
populations are necessary to evaluate the effects of 
smoking on salivary components and oral conditions.
Conclusion
In the current study, salivary ALP activity levels, pH 
and BC were significantly decreased among smokers 
in comparison to non-smokers. These findings are 
probably due to the deleterious effect of smoking 
on the oral environment, including saliva. Salivary 
changes in smokers may therefore be potential 
biochemical markers of the functional condition of 
the oral tissues, which could consequently help in the 
diagnosis of various conditions and the evaluation 
of the effect of smoking on oral and dental health. 
Further longitudinal studies should be carried out to 
understand the true effects of smoking on saliva and 
its components.
conflict of interest
The authors declare no conflicts of interest.
funding
No funding was received for this study.
References
1. Ahmadi Motamayel F, Davoodi P, Dalband M, Hendi S. Saliva as 
a mirror of the body health. Avicenna J Dent Res 2010; 1:1–15.
2. Schipper RG, Silletti E, Vingerhoeds MH. Saliva as research 
material: Biochemical, physicochemical and practical 
aspects. Arch Oral Biol 2007; 52:1114–35. doi: 10.1016/j.
archoralbio.2007.06.009.
3. Dabra S, China K, Kaushik A. Salivary enzymes as diagnostic 
markers for detection of gingival/periodontal disease and 
their correlation with the severity of the disease. J Indian Soc 
Periodontol 2012; 16:358–64. doi: 10.4103/0972-124X.100911.
4. Dabra S, Singh P. Evaluating the levels of salivary alkaline 
and acid phosphatase activities as biochemical markers for 
periodontal disease: A case series. Dent Res J (Isfahan) 2012; 
9:41–5. doi: 10.4103/1735-3327.92942.
5. Yoshie H, Tai H, Kobayashi T, Oda-Gou E, Nomura Y, 
Numabe Y, et al. Salivary enzyme levels after scaling and 
interleukin-1 genotypes in Japanese patients with chronic 
periodontitis. J Periodontol 2007; 78:498–503. doi: 10.1902/
jop.2007.060216.
6. Warnes TW. Alkaline phosphatase. Gut 1972; 13:926–37. 
doi: 10.1136/gut.13.11.926.
7. Dawes C. What is the critical pH and why does a tooth dissolve 
in acid? J Can Dent Assoc 2003; 69:722–4. 
8. Owlia F, Akhavan Karbassi M, Ahadian H, Kazemeiny K. 
Comparison of salivary pH in diabetic patients referring to 
Diabetes Center of Shahid Sadoughi University of Medical 
Sciences with non-diabetic controls. J Shahid Sadoughi Univ 
Med Sci 2012; 20:82–9.
9. Bardow A, Moe D, Nyvad B, Nauntofte B. The buffer capacity 
and buffer systems of human whole saliva measured without 
loss of CO2. Arch Oral Biol 2000; 45:1–12. doi: 10.1016/s0003-
9969(99)00119-3.
10. Cheaib Z, Lussi A. Role of amylase, mucin, IgA and albumin on 
salivary protein buffering capacity: A pilot study. J Biosci 2013; 
38:259–65. doi: 10.1007/s12038-013-9311-1.
11. Dodds MW, Johnson DA, Yeh CK. Health benefits of saliva: A 
review. J Dent 2005; 33:223–33. doi: 10.1016/j.jdent.2004.10.009.
12. Kaur A, Kwatra KS, Kamboj P. Evaluation of non-microbial 
salivary caries activity parameters and salivary biochemical 
indicators in predicting dental caries. J Indian Soc Pedod Prev 
Dent 2012; 30:212–17. doi: 10.4103/0970-4388.105013.
13. Bagherian A, Asadikaram G. Comparison of some salivary 
characteristics between children with and without early 
childhood caries. Indian J Dent Res 2012; 23:628–32. doi: 10.41 
03/0970-9290.107380.
14. Farsi N. Dental caries in relation to salivary factors in Saudi 
population groups. J Contemp Dent Pract 2008; 9:16–23.
15. Saggu TK, Masthan KM, Dudanakar MP, Nisa SU, Patil S. 
Evaluation of salivary antioxidant enzymes among smokers 
and nonsmokers. World J Dent 2012; 3:18–21. doi: 10.5005/jp-
journals-10015-1121.
16. Bakhtiari S, Bigom Taheri J, Bakhshi M, Mortazavi H, 
Shah Hoseini A, Vahid Dastjerdi E, et al. Effect of vitamin C on 
salivary total antioxidant capacity in smokers. Iran J Pharm Res 
2012; 11:1045–9.
17. Buduneli N, Kardeşler L, Işik H, Willis CS 3rd, Hawkins SI, 
Kinane DF, et al. Effects of smoking and gingival inflammation 
on salivary antioxidant capacity. J Clin Periodontol 2006; 
33:159–64. doi: 10.1111/j.1600-051x.2006.00892.x.
18. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 
1993; 694:72–7. doi: 10.1111/j.1749-6632.1993.tb18343.x.
Fatemeh Ahmadi-Motamayel, Parisa Falsafi, Mohammad T. Goodarzi and Jalal Poorolajal
Clinical and Basic Research | e321
19. Tulunoglu O, Demirtas S, Tulunoglu I. Total antioxidant 
levels of saliva in children related to caries, age, and gender. 
Int J Paediatr Dent 2006; 16:186–91. doi: 10.1111/j.1365-
263X.2006.00733.x.
20. Pink R, Simek J, Vondrakova J, Faber E, Michl P, Pazdera J, 
et al. Saliva as a diagnostic medium. Biomed Pap Med Fac Univ 
Palacky Olomouc Czech Repub 2009; 153:103–10. doi: 10. 
5507/bp.2009.017. 
21. Mahesh DR, Komali G, Jayanthi K, Dinesh D, Saikavitha TV, 
Dinesh P. Evaluation of salivary flow rate, pH and buffer in pre, 
post & post menopausal women on HRT. J Clin Diagn Res 2014; 
8:233–6. doi: 10.7860/JCDR/2014/8158.4067.
22. Shaila M, Pai GP, Shetty P. Salivary protein concentration, flow 
rate, buffer capacity and pH estimation: A comparative study 
among young and elderly subjects, both normal and with 
gingivitis and periodontitis. J Indian Soc Periodontol 2013; 
17:42–6. doi: 10.4103/0972-124X.107473.
23. Kibayashi M, Tanaka M, Nishida N, Kuboniwa M, Kataoka K, 
Nagata H, et al. Longitudinal study of the association between 
smoking as a periodontitis risk and salivary biomarkers related 
to periodontitis. J Periodontol 2007; 78:859–67. doi: 10.1902/
jop.2007.060292.
24. Hegde M, Malhotra A, Hegde N. Salivary pH and buffering 
capacity in early and late human immunodeficiency virus 
infection. Dent Res J (Isfahan) 2013; 10:772–6.
25. Cutando A, López-Valverde A, Gómez-de-Diego R, Arias-
Santiago S, de Vicente-Jiménez J. Effect of gingival application 
of melatonin on alkaline and acid phosphatase, osteopontin and 
osteocalcin in patients with diabetes and periodontal disease. 
Med Oral Patol Oral Cir Bucal 2013; 18:e657–63. doi: 10.4317/
medoral.18832. 
26. Flórez-Moreno GA, Marín-Restrepo LM, Isaza-Guzmán DM, 
Tobón-Arroyave SI. Screening for salivary levels of 
deoxypyridinoline and bone-specific alkaline phosphatase 
during orthodontic tooth movement: A pilot study. Eur J 
Orthod 2013; 35:361–8. doi: 10.1093/ejo/cjr138.
27. Guerra RN, Oliveira-Junior JJ, Mouchrek-Filho JC, Liberio SA, 
Lima MV, Paim DB, et al. Salivary evaluation of pediatric 
patients with cancer, before and after antineoplasic treatment. 
J Oral Pathol Med 2012; 41:527–32. doi: 10.1111/j.1600-0714. 
2012.01165.x.
28. Nagler RM, Klein I, Reznick AZ. [The interaction between 
saliva and cigarette smoke and its devastating biological effects 
as related to oral cancer]. Harefuah 2001; 140:614–18. 
29. Sukhareva AE, Bulakh NA, Ermolaeva TN, Nikolaeva AA. 
[Alkaline phosphatase in mixed saliva in abdominal inflammatory 
diseases and gestoses]. Klin Lab Diagn 2011; 6:16–18. 
30. Ketabi M, Mesripour M, Rafiei E. The comparison of GCF 
and salivary level of ALP in smokers, non-smokers with 
periodontitis and in healthy subjects. J Res Dent Sci 2015; 
11:236–41.
31. Abdul Ameer LR, Ali BG. Effects of light smoking on salivary 
levels of alkaline phosphatase and osteocalcin in chronic 
periodontitis patients. J Baghdad Coll Dent 2015; 27:110–14. 
doi: 10.12816/0015305. 
32. Kubota M, Yanagita M, Mori K, Hasegawa S, Yamashita M, 
Yamada S, et al. The effects of cigarette smoke condensate 
and nicotine on periodontal tissue in a periodontitis model 
mouse. PLoS One 2016; 11:e0155594. doi: 10.1371/journal.
pone.0155594.
